Platinum-induced ototoxicity
MONDO:0800178Progressive, bilateral, and irreversible sensorineural hearing loss as a frequently encountered side effect of platinum-based chemotherapy such as cisplatin and carboplatin.
Also known as: deafness, platinum-induced, platinum-related ototoxicity
7 clinical trials for this condition and its sub-types, 4 tagged with Platinum-induced ototoxicity itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Massive study tests Blood-Cleaning therapy for poisoning victims
Disease control OngoingThis study looks at whether blood-filtering treatments, such as dialysis or plasma exchange, can help people survive acute poisoning. Researchers will compare over 5,000 poisoned patients who received these treatments with those who did not. The goal is to see if the treatments i…
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New pill aims to stop chemo from stealing hearing
Prevention CancelledThis study was designed to test whether an oral drug called SPI-1005 could prevent hearing loss and ringing in the ears caused by platinum-based chemotherapy. It was planned for adults with advanced lung or head and neck cancer. The study was withdrawn before enrolling any partic…
Phase 2 • Sponsor: Sound Pharmaceuticals, Incorporated • Aim: Prevention
Last updated Jun 27, 2026 13:01 UTC